Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request | The Manila Times

 Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delivery system

Ähnliche Seiten

https://www.manilatimes.net/2026/06/23/tmt-newswire/globenewswire/silo-pharma-reports-positive-stability-data-for-spc-15-ptsd-treatment-advancing-program-toward-first-in-human-clinical-trial/2370945

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial | The Manila Times

https://www.manilatimes.net/2026/06/23/tmt-newswire/globenewswire/silo-pharma-reports-positive-stability-data-for-spc-15-ptsd-treatment-advancing-program-toward-first-in-human-clinical-trial/2370945